Patrick McLeroth
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 3
- Clostridium difficile and Clostridium perfringens research 3
-
- Urinary Tract Infections Management 2
- Co-authors
- Amanda Paschke (3 shared papers)Nicholas A. Kartsonis (3 shared papers)Alison Pedley (3 shared papers)Yu‐Chieh Lee (1 shared paper)Jiejun Du (1 shared paper)Michelle Brown (2 shared papers)Matthew Sims (1 shared paper)Michelle Brown (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)Clinical Infectious Diseases (1 paper)Transplant International (1 paper)New England Journal of Medicine (1 paper)Nuclear Medicine and Biology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Patrick McLeroth
12 papers receiving 540 citations
Patrick McLeroth's Hit Papers
Peers
Comparison fields: 5 of 60
- Applied Microbiology and Biotechnology 150
- Molecular Medicine 331
- Clinical Biochemistry 100
- Pharmacology 239
- Critical Care and Intensive Care Medicine 52
Countries citing papers authored by Patrick McLeroth
This map shows the geographic impact of Patrick McLeroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick McLeroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick McLeroth more than expected).
Fields of papers citing papers by Patrick McLeroth
This network shows the impact of papers produced by Patrick McLeroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick McLeroth. The network helps show where Patrick McLeroth may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick McLeroth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 144 | |
| 2 | 2017 | 126 | |
| 3 | 2019 | 87 | |
| 4 | Cefepime–Taniborbactam in Complicated Urinary Tract Infection Hit paper breakdown → | 2024 | 67 |
| 5 | 2017 | 41 | |
| 6 | 2016 | 37 | |
| 7 | 2018 | 31 | |
| 8 | 2017 | 8 | |
| 9 | 2002 | 6 | |
| 10 | 2019 | 5 | |
| 11 | 2002 | 1 | |
| 12 | A Phase 2 Study to Evaluate the Efficacy & Safety of Relebactam (REL) + Imipenem/Cilastatin (IMI) vs IMI Alone in Subjects with Complicated Intra-Abdominal Infection (cIAI) | 2015 | 1 |
About Patrick McLeroth
Patrick McLeroth is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Pulmonary and Respiratory Medicine and Clinical Biochemistry, having authored 12 papers that have together received 554 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Antibiotic Resistance in Bacteria (3 papers), Respiratory Support and Mechanisms (2 papers), Neonatal Respiratory Health Research (2 papers) and Urinary Tract Infections Management (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (150 citations), Molecular Medicine (331 citations), Clinical Biochemistry (100 citations), Pharmacology (239 citations) and Critical Care and Intensive Care Medicine (52 citations). Patrick McLeroth has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Amanda Paschke, Nicholas A. Kartsonis, Alison Pedley, Yu‐Chieh Lee, Jiejun Du, Michelle Brown, Matthew Sims, Michelle Brown, Mallika Lala and Matthew L. Rizk. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Transplant International, New England Journal of Medicine and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.